EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

SARS‐CoV ‐2 testing, positivity, and factors associated with COVID‐19 among people with HIV across Europe in the multinational EuroSIDA cohort

O Fursa iD, W Bannister iD, B Neesgaard, D Podlekareva iD, J Kowalska iD, T Benfield, J Gerstoft, J Reekie iD, L D Rasmussen, I Aho, G Guaraldi iD, T Staub und 12 weitere

HIV Medicine · 2024

DOI: 10.1111/hiv.13620 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift HIV Medicine, 2024. Verfasst von O Fursa und 23 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: COVID-19, HIV Infections, SARS-CoV-2, Hospitalization. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although people with HIV might be at risk of severe outcomes from infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2; coronavirus 2019 [COVID‐19]), regional and temporal differences in SARS‐CoV‐2 testing in people with HIV across Europe have not been previously described.

Methods

We described the proportions of testing, positive test results, and hospitalizations due to COVID‐19 between 1 January 2020 and 31 December 2021 in the EuroSIDA cohort and the factors associated with being tested for SARS‐CoV‐2 and with ever testing positive.

Results

Of 9012 participants, 2270 (25.2%, 95% confidence interval [CI] 24.3–26.1) had a SARS‐CoV‐2 polymerase chain reaction test during the study period (range: 38.3% in Northern to 14.6% in Central‐Eastern Europe). People from Northern Europe, women, those aged

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HIV InfectionsSARS-CoV-2HospitalizationHumansFemaleMaleEuropeAdultMiddle AgedCOVID-19 TestingCohort StudiesRisk FactorsCD4 Lymphocyte CountAged

Stichwörter der Autor:innen

COVID‐19EuropeHIVSARS‐CoV‐2 testing

Autor:innen und Institutionen

  • Centre of Excellence for Health, Immunity and Infections, Rigshospitalet, Copenhagen, Denmark.
  • Department of Respiratory and Infectious Diseases, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Department of Adults' Infectious Diseases, Medical University of Warsaw, Warsaw, Poland.
  • Department of Infectious Diseases, Copenhagen University Hospital-Amager and Hvidovre, Hvidovre, Denmark.
  • Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
  • Department of Infectious Diseases, Odense University Hospital, Odense, Denmark.

ORCID-Profile: O Fursa, W Bannister, D Podlekareva, J Kowalska, J Reekie, G Guaraldi

Zitieren

APA

Fursa, O., Bannister, W., Neesgaard, B., Podlekareva, D., Kowalska, J., Benfield, T., Gerstoft, J., Reekie, J., Rasmussen, L. D., Aho, I., Guaraldi, G., Staub, T., Miro, J. M., Laporte, J. M., Elbirt, D., Trofimova, T., Sedlacek, D., Matulionyte, R., Oprea, C., …, & EuroSIDA Study Group (2024). SARS‐CoV ‐2 testing, positivity, and factors associated with COVID‐19 among people with HIV across Europe in the multinational EuroSIDA cohort. HIV Medicine. https://doi.org/10.1111/hiv.13620

Vancouver

Fursa O, Bannister W, Neesgaard B, Podlekareva D, Kowalska J, Benfield T, et al. SARS‐CoV ‐2 testing, positivity, and factors associated with COVID‐19 among people with HIV across Europe in the multinational EuroSIDA cohort. HIV Medicine. 2024. doi:10.1111/hiv.13620

BibTeX
@article{Fursa2024,
  author = {Fursa, O and Bannister, W and Neesgaard, B and Podlekareva, D and Kowalska, J and Benfield, T and Gerstoft, J and Reekie, J and Rasmussen, L D and Aho, I and Guaraldi, G and Staub, T and Miro, J M and Laporte, J M and Elbirt, D and Trofimova, T and Sedlacek, D and Matulionyte, R and Oprea, C and Bernasconi, E and Hadžiosmanović, V and Mocroft, A and Peters, L and EuroSIDA Study Group, EuroSIDA Study Group},
  title = {SARS‐CoV ‐2 testing, positivity, and factors associated with COVID‐19 among people with HIV across Europe in the multinational EuroSIDA cohort},
  journal = {HIV Medicine},
  year = {2024},
  doi = {10.1111/hiv.13620}
}
Kostenlos starten →